Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
ConclusionsFosfomycin trometamol might be a reasonable option as step-down therapy in patients with BUTI due to MDR-Ec but the higher rate of relapses would need further assessment.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research
More News: Amoxicillin | Bactrim | Ceftriaxone | Cefuroxime | Chemotherapy | Cipro | Ciprofloxacin | Gastroenteritis | Microbiology | Rocephin | Spain Health | Sulfamethoxazole | Trimethoprim | Urinary Tract Infections